Persons living with HIV (PLWH) today can survive decades with the disease, making the symptom experience much more relevant to their lifestyle and health outcomes. The goal of the research reported here was to assess the symptom reporting of PLWH in the Unites States (US) in the combined antiretroviral therapy (cART) age of the epidemic. We conducted an anonymous online survey of symptomatic PLWH in the US and asked participants to report the frequency and intensity of 28 frequently occurring symptoms in the past 30 days. The relationship between symptom reporting and demographic factors was investigated using the adaptive least absolute shrinkage and selection operator (LASSO) method. Fatigue was the most frequently reported symptom in our study population. Those with the lowest income were more likely to report more burdensome symptoms. In comparison to other racial and ethnic groups, Black nonHispanic participants were significantly more likely to report a lower symptom burden score for fatigue, depression, muscle aches, anxiety, difficulties with memory and concentration. There were no racial/ ethnic differences in the burden of the symptoms related to sleep or neuropathy. Findings from this study present new evidence on the symptom reporting of PLWH in the US. Neuropathy continues to be a pervasive neurological symptom with no difference noted between racial/ ethnic groups.
Introduction
Persons living with chronic diseases often have a high burden of symptoms, which can affect their quality of life, physical functioning and overall health (AbdelKader, Unruh, & Weisbord, 2009; Blinderman, Homel, Billings, Tennstedt, & Portenoy, 2009; Molarius & Janson, 2002; Nelson et al., 2004; Centers for Disease Control and Prevention, 2016b; Walke, Gallo, Tinetti, & Fried, 2004) . In contrast to the high mortality rate in the early days of the HIV epidemic, persons living with HIV (PLWH) today can, with current combination antiretroviral therapy (cART), survive decades with the disease, making the symptom experience of the disease much more relevant to their lifestyle and health outcomes. The symptom experience of PLWH was well-studied in the early years of the epidemic. Symptoms experienced by PLWH were associated with a negative impact on quality of life (Andrinopoulos et al., 2011; Biraguma & Rhoda, 2012; Ellis et al., 2010; Kempf et al., 2009; Vyavaharkar, Moneyham, Murdaugh, & Tavakoli, 2012) , poorer health and functioning (Andrinopoulos et al., 2011; Deeks, 2011; Erlandson et al., 2013; Fierz et al., 2013; Harding et al., 2012; Merlin et al., 2012) , and poorer adherence to ART (Gay et al., 2011; Harding et al., 2010) . In fact, research has shown that quality of life and productivity decrease as the number and severity of HIV-related symptoms increase (Lorenz, Cunningham, Spritzer, & Hays, 2006; Siegel, Schrimshaw, & Dean, 1999) .
Even though HIV has evolved from a life-threatening progressive illness to a manageable chronic condition, PLWH often experience re-occurring symptoms from the disease, its treatment, and co-morbid conditions (Cook, Sousa, Matthews, Meek, & Kwong, 2011; Iribarren et al., 2017) . Consequently, Much of the research on the symptom experience among PLWH is dated (Holzemer, 2002; Hudson, Kirksey, & Holzemer, 2004; Makoae et al., 2005; Mathews et al., 2000; Shawn, Campbell, Mnguni, Defilippi, & Williams, 2005; Sukati et al., 2005; Tsai, Hsiung, & Holzemer, 2002; VanRaden, MA, Kingsley, & Phain, 1989; van Servellen, Sarna, & Jablonski, 1998) , restricted to single site studies (Buseh, Kelber, Stevens, & Park, 2008; Rivero-Mendez, Portillo, Solis-Baez, Wantland, & Holzemer, 2009; Schnall, Wantland, Velez, Cato, & Jia, 2014; Wilson et al., 2016) , and based on old symptom indexes (Buseh et al., 2008; Coleman et al., 2006; Hudson et al., 2004; Johnson et al., 2005; Makoae et al., 2005; Peltzer & Phaswana-Mafuya, 2008; Trevino et al., 2010; Webel et al., 2015; Wilson et al., 2016) . Therefore, it is clear that the symptom experience of PLWH today needs to be understood in the context of cART, including once a day regimens, long-term adherence to ART medications, and age-related comorbidities as opposed to illness progression and toxicity associated with early ART regimens (Cook et al., 2011) .
Another area in need of further understanding relates to racial, ethnic and socioeconomic differences in symptom burden. Past research has shown that those from low socioeconomic groups are more likely to report higher symptom burden (Peltzer, 2013; Voss, 2005) . In contrast, racial and ethnic differences in symptom burden are inconclusive with some studies finding symptom burden to differ between racial/ ethnic groups (Brandt, Zvolensky, Daumas, Grover, & Gonzalez, 2016; Johnson et al., 2005; Webel et al., 2015; Wilson et al., 2016) , and others finding no significant differences between groups (Hudson et al., 2004; Pérez et al., 2009; Trevino et al., 2010) . Overall, the literature on HIV self-reported data is very sparse and has mainly focused on self-reported CD4 counts and health service utilization among marginalized populations living with HIV (Cunningham, Li, Ramsey, & Sohler, 2007; Voss et al., 2015) . Given the mixed findings and the dearth of existing evidence, our study examines racial, ethnic and socioeconomic differences in symptom reporting in PLWH.
Methods
After securing approval from the Columbia University Medical Center Institutional Review Board, we conducted an anonymous online survey of PLWH in the US from February to August 2016. Study participants were recruited through banner ads placed on the following sites: Facebook, Craiglist, POZ, BGCLive, and the Well Project. Participants were eligible for the study if they were HIV+, 18 years or older, able to read and respond in English, resided within the US, reported having experienced symptoms in the past 4 weeks, and were willing to participate in an online survey.
Participants who clicked on the study banner advertisements (see Figure 1) were automatically directed to a study landing page that screened potential participants. The screening survey, administered through Qualtrics, included questions related to the eligibility criteria described above. If they qualified for the study, then participants were directed to complete the consent form. Study participants were asked: (1) "In the past 30 days, which of the following 28 symptoms made it difficult to carry out your daily activities? (Check all that apply)" (Table 2 ). Participants were then asked to rate on a 4 point scale: (2) "how often they experienced the symptom and how much the symptom interfered with their day to day activities in the past 30 days?" In addition, study participants were asked to complete demographic questions and identify self-care strategies they had used to ameliorate their symptoms. These results are reported elsewhere (Iribarren et al., Under Review) . Participants were also asked whether they had any of the following HANA conditions: asthma, bronchitis, cardiovascular disease, COPD, diabetes, liver disease, osteoporosis, renal failure, and arthritis.
We implemented a number of precautionary measures to prevent fraud in our study. Including: no incentive payments, trap questions and a reCAPTCHA code.
Data management and analysis
Data were downloaded from Qualtrics to Excel. Data were first examined to ensure that there were no duplicate responses (e.g., multiple entries by the same person).
Descriptive statistics were used to analyze the demographic characteristics of the study participants. We developed a symptom score which incorporated the frequency and bothersomeness of each symptom. If frequency is "No" then score = 0; If frequency is not "No" and bothersome is "A little" then score = 1; If frequency is not "No" and bothersome is "somewhat" then score = 2; If frequency is not "No" and bothersome is "quite a bit" then score = 3; If frequency is not "No" and bothersome is "very much" then score = 4. This scoring was based on the Memorial Symptom Assessment Scale, an index that combines frequency and bothersomeness to capture symptom burden in oncology and AIDS patients (Chang, Once we developed a symptom score for each participant, we estimated the mean and corresponding S.E. of each score. For multivariable analyses, we focused on the 9 most frequently reported symptoms. Our initial multiple regression model included the following independent variables: age, sex, race, ethnicity, sexual orientation, number of HANA conditions, AIDS diagnosis, income and employment. We used the adaptive LASSO (least absolute shrinkage and selection operator) method to select the final model since it produces better prediction accuracy and interpretability of the statistical models than the commonly used stepwise selection and backward elimination methods when there are a large number of possible predictive variables and many of these variables are correlated (Zou, 2006) . To illustrate, we used dummy variables for categorical variables. Predictors are automatically selected based on the LASSO method. There is no traditional significance test with the LASSO method and so the final model typically excludes some dichotomized variables that were initially categories within a categorical variable.
Results

Study sample
1373 completed the entire survey and are included in our sample. Demographics of the study sample are included in Table 1 . We had respondents from all 50 states with the most respondents in California (N = 231) and the fewest number in West Virginia (N = 1).
A symptom score was calculated based on frequency and bothersomeness with daily activities and was based on Memorial Symptom Assessment Scale. The mean (S.E.) and frequency of the symptom burden score in order of severity is reported in Table 2 . Fatigue was the most frequently reported symptom in our study population, followed by depression, muscle aches, and difficulty falling asleep. Pain or discomfort during sex was the least frequently reported symptom.
Symptom clustering
We identified symptoms that were highly correlated by identifying groups of highly related symptoms based on the percent of variance explained in disjoint symptoms clusters. Five symptoms clusters were identified from the 28 symptoms ( Figure 2 ): (1) Fatigue, nausea, diarrhea, and depression; (2) constipation, thirst, and dry eyes; (3) cough, fever, shortness of breath, heartburn; (4) speech, difficulty concentrating and memory; and (5) urination, erection problems, painful sex, and decreased sex drive. The total percent of variance explained by the 5 clusters was 40% (0.3996). The results of our multi-regression analysis of the 9 most frequently reported symptoms are reported in Table 3 . For almost all of the symptoms, those with the lowest income (less than $20,000/ year), as compared to those with higher incomes, were more likely to report more burdensome symptoms for the top nine symptoms. Having fewer HANA conditions was predictive of less burdensome symptom reporting for all of the 9 most frequently reported symptoms except depression and difficulty falling asleep. In comparison to other racial and ethnic groups, including White non-Hispanics, Hispanics and others, Black non-Hispanic participants were significantly more likely to report a lower symptom burden score for fatigue, depression, muscle aches, anxiety, difficulties with memory and concentration. There were no racial/ ethnic differences in the burden of the symptoms related to sleep or neuropathy.Women reported significantly greater symptom burden for muscle aches only. Those working full-time reported significantly lower symptom burden for neuropathy. Those diagnosed with AIDS had significantly greater symptom burden for fatigue, difficulty with memory, and neuropathy, though those with a recent low CD4 count (< 200) had a significantly lower symptom score for difficulty with memory, adjusting for AIDS diagnosis.
Discussion
Despite advances in cART medications, adverse symptoms in PLWH continue to be common. As the demographic profile of PLWH continues to evolve, the symptom experience of PLWH may be further influenced by individual clinical and non-clinical characteristics. By means of an online survey, our national study aimed to capture symptom reports from PLWH in the cART era. Specifically, we sought to reach a large sample of PLWH to characterize symptom reports by racial, ethnic, and socioeconomic differences. Online recruitment allowed us to reach a large, geographically, racially, ethnically and socioeconomically diverse group of PLWH and employed a quick medium to enroll participants.
Past research on symptoms among PLWH has focused on topics such as symptom experience and incidence (Brown, Whiteley, Harper, Nichols, & Nieves, 2015; Holzemer, 2002; Makoae et al., 2005; Mathews et al., 2000; Peltzer & Phaswana-Mafuya, 2008; Shawn et al., 2005; VanRaden et al., 1989; van Servellen et al., 1998) , as well as symptom management (Burack, Cohen, Hahn, & Abrams, 1996; Pérez et al., 2009; Sukati et al., 2005; Trevino et al., 2010; Webel et al., 2015; Zou, Wang, & Liu, 2016) . Many of the prior studies of the symptom experience and incidence in PLWH were conducted at a single site (Buseh et al., 2008; Rivero-Mendez et al., 2009; Wilson et al., 2016) or were conducted before the age of cART (Kelly et al., 1993; Lenz, Pugh, Milligan, Gift, & Suppe, 1997; VanRaden et al., 1989; van Servellen et al., 1998) . We did not use two frequently used HIV symptom indexes since these instruments were developed before the advent of advanced cART (Pettersen et al., 2006; Smyth et al., 2007) . Instead, the symptom data reported in this survey presents outputs from earlier work. We presented our study participants with a large array (N = 28) of symptom choices that could best capture the full range of possible symptoms. Our selection of 28 symptoms was based on the number of symptoms from past surveys of PLWH, and the selection of specific symptoms was based on most frequently reported symptoms in past studies. For example, in a study in the Washington, D.C. area, PLWH experienced an average of 15.2 out of 39 listed symptoms (38.97%) (Wu et al., (18-44, 45-54, 55-64, 65+, missing) ; sexual orientation (bisexual, heterosexual, homosexual, missing); race (Black non-Hispanic, White non-Hispanic, Hispanic, other, missing); education (some high school or less, high school/GED/some college/associates degree/technical school, 4-year college graduate or higher, missing); employment (full time, part time, other/no full time job/no part time job); income (< $20,000, $20,000-$60,000, > = $60,000, missing); CD4 count (< 200, 200-349, 350-499, 500+) ; AIDS diagnosis (yes, no, don't know).
2004). In another study in New York City, Baltimore, and Alabama, PLWH reported that they experienced an average of 10.9 (34.06%), 11.9 (37.19%), and 12.7 (39.69%) of 32 listed symptoms, respectively (Karus et al., 2005) . The 2000 iteration of the National HIV Costs and Services Utilization Survey indicated that at least 50% PLWHA in the United States report experiencing up to seven out of fourteen HIV/AIDS-related symptoms within a six-month period (50%) and less than 10% of PLWH report no symptoms (Mathews et al., 2000) . Finally, a study of 504 PLWH in New York City who also had chronic conditions noted that this population experienced on average 16.7 out of 32 symptoms at the time that they received care from a physician (Vogl et al., 1999) .
In three other studies, the symptom profiles of those living with HIV were similar to some of the findings in our study, with fatigue being the most frequently reported symptom (Chou, Holzemer, Portillo, & Slaughter, 2004; Wantland et al., 2008; Wilson et al., 2016) . Despite the changes in management of the disease and its treatment, fatigue persists as a burdensome symptom among PLWH. The etiology of fatigue is multifactorial and has been associated with various physiologic and psychological factors including being attributed to the long-term effects of inflammation from the virus (Klimas, Broderick, & Fletcher, 2012; Wilson et al., 2014) , whose mechanism is still not well-understood.
Depression, muscle aches, anxiety and difficulty with sleep were among the top 10 most frequently reported symptoms across multi-site studies as well as in more recent single site studies. These findings are similar to the symptom frequencies that we identified in our large national study. In contrast to earlier studies, thirst and diarrhea were infrequently reported in our study sample and were also not reported as being very burdensome (Table 2 ). The improvement in diarrhea in our current study population is to be expected, given improvements in protease inhibitors (Bini & Cohen, 1999; Foudraine et al., 1998) .
Similar to past research, our study found that neuropathy is the most common neurological complication in HIV. Past studies estimate that approximately 30%-60% of PLWH report symptoms of neuropathy (Pettersen et al., 2006; Smyth et al., 2007; Woldeamanuel et al., 2016) . We found that just under 30% of our participants reported symptoms of neuropathy. Past research also suggests that neuropathy is associated with taking ART. The lower incidence of neuropathy in our study sample is likely attributable to improvements in ART, as many of those studies are dated. It may also be a result of selection bias in some of the smaller studies that focus only on PLWH with neuropathy symptoms, since people report a high burden associated with this symptom and therefore may be more likely to seek help and participate in studies related to their symptom burden (Cherry, Wadley, & Kamerman, 2016; Sandoval, Roddey, Giordano, Mitchell, & Kelley, 2013; Schütz & RobinsonPapp, 2013) .
Past studies of symptoms among PLWH have focused on identifying symptom clusters (Brandt et al., 2016; Wilson et al., 2016) , as symptoms often have moderating and mediating effects on one another (Lenz et al., 1997; Martinez et al., 2012) . For example, the symptom cluster of weight loss, polydipsia, polyuria and polyphagia is often associated with the diagnosis of diabetes (Wilson et al., 2016) . Of the five symptom clusters represented in our survey data, four can be easily understood. For instance, constipation, thirst, and dry eyes are often associated with dehydration; speech, difficulty concentrating and remembering are associated with neurological deficit; cough, fever, shortness of breath and heartburn are often represented by a compromised respiratory system; and urination, difficulty with erection, decreased sex drive and painful sex are all related to the genito-urinary system. The first symptom cluster, fatigue, nausea, diarrhea, and depression, cannot be as easily explained and has not been reported previously in the literature as being highly related.
Socioeconomic differences in the symptom experience have been noted in previous studies. There is strong evidence across studies that PLWH with higher annual income and who are employed have lower symptom scores Mathews et al., 2000; Webel et al., 2015) . Similarly, in our study, across symptoms there was a significantly higher symptom score reported among PLWH with the lowest level of income (< $20,000 per year) as compared to other income levels. We also found PLWH working full-time reported a lower symptom score for neuropathy.
In past studies, there have been mixed findings on racial/ ethnic disparities in symptom reporting in PLWH. One study found that being of race was associated with reporting a greater number of symptoms and greater level of symptom bothersomeness (Mathews et al., 2000) , in contrast to findings of another study that being of White or race, compared to Hispanic, was negatively related to symptom intensity (Webel et al., 2015) . In another study, compared to Blacks and Hispanics, Whites reported higher prevalence of: fatigue, sadness, poor sleep, nervousness/anxiousness, and memory loss (Wilson et al., 2016) . The inconclusive evidence across these studies made our analysis highly relevant.
In our study, Hispanic descent was not a significant predictor for symptom reporting across all symptoms. However, being Black/non-Hispanic, compared to any other racial group, was a significant predictor for reporting the following symptoms as being less burdensome: fatigue, depression, muscle aches, anxiety, difficulties with memory and concentration. The key finding that non-Hispanics report fewer symptoms in several categories is noteworthy especially in light of past research. A limitation to this findings is that it is difficult to tell whether this difference is due to non-Hispanics being less likely to report the symptoms or to them truly having fewer symptoms. Research on differences in selfreported symptoms by race/ethnicity is not concrete. Past studies with similar findings have suggested that this difference may be due to genetic differences or differences in social support and self-care strategies (Lee et al., 2009; Silverberg, Jacobson, French, Witt, & Gange, 2009) .
Moreover, there were no racial differences in symptom burden of sleep difficulties or neuropathy. As discussed earlier, the physiologic basis for symptoms related to neuropathy may be different than the other symptoms that we explored. The uniformity of the symptom reporting across racial/ ethnic groups may suggest that there is a unique mechanism that underlies this symptom in PLWH.
Limitations
There are a number of limitations to our study. First, there is a possibility for self-selection bias, as participants who are willing to participate in a health-related survey may be more likely to be experiencing healthrelated issues. The inclusion criteria of needing to report having experienced symptoms in the past 4 weeks has the potential to introduce bias in understanding symptom differences and may not be representative of the general population of PLWH. Second, all information collected as part of our survey was self-reported and may include over or underreporting of symptom burden. While a validated scale was used to score symptoms, symptom validity remains a challenging concept to define and manage and often requires a multi-method approach, involving both individual and clinical reports, specifically in the context of mental health. However, in other clinical contexts, such as cancer, symptom validity measures have demonstrated high agreement between patient and clinician reports (Basch et al., 2006) . Finally, past research has suggested that there is a digital divide and this would likely influence our sampling strategy, yet current estimates suggest that 88% of Americans use the Internet with no differences in racial and ethnic groups and the largest differences in use are by income and age groups, with older and lower-income Americans being less likely to use the Internet (Demographics of Internet and Home Broadband Usage in the United States, 2017). At the same time, our study sample mirrored the current national estimates of the age and income of PLWH, demonstrating the generalizability of our findings (Center for Disease Control and Prevention, 2015, 2016a) . Given the widespread use of the Internet across racial, ethnic, socioeconomic groups (Perrin & Duggan, 2015) and the widespread distribution across these groups in our study sample, it is unlikely that this sampling bias affected our survey data (Justice et al., 2001 ).
Conclusion
Findings from this study present new evidence on the symptom reporting of a national sample of PLWH in the US. Fatigue continues to be the most prevalent symptom in PLWH even as the controllability of the disease and its treatment have progressed. The decreases in reporting of diarrhea and thirst are notable as well and likely attributable to advancements in treatment. In comparison to other racial and ethnic groups, including white non-Hispanics, Hispanics and others, black nonHispanic participants were significantly more likely to report fewer symptoms except in the case of neuropathy, which continues to be a pervasive neurological symptom with no difference noted between racial/ ethnic groups.
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